Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on: November 09,2024 0

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on:November 09,2024 0

Breakdown of normal 3-D shape of DNA allows harmful interactions of genes in rare form of gastrointestinal stromal tumor

by Massachusetts General HospitalCredit: CC0 Public DomainMost cases of gastrointestinal stromal tumor (GIST), a type of soft-tissue cancer (sarcoma), are caused by mutations in genes that can be

Updated on: April 20,2024 17

Breakdown of normal 3-D shape of DNA allows harmful interactions of genes in rare form of gastrointestinal stromal tumor

by Massachusetts General HospitalCredit: CC0 Public DomainMost cases of gastrointestinal stromal tumor (GIST), a type of soft-tissue cancer (sarcoma), are caused by mutations in genes that can be

Updated on:April 20,2024 17

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on: June 08,2024 5

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on:June 08,2024 5

Merck, Moderna detail potential skin cancer vaccine progress

by Tom MurphyA sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a p

Updated on: January 02,2024 6

Merck, Moderna detail potential skin cancer vaccine progress

by Tom MurphyA sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a p

Updated on:January 02,2024 6

Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment

by Rutgers UniversityCredit: Pixabay/CC0 Public DomainInvestigators from Rutgers Cancer Institute of New Jersey, the state's leading cancer center and only National Cancer Institute-Designate

Updated on: February 01,2024 17

Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment

by Rutgers UniversityCredit: Pixabay/CC0 Public DomainInvestigators from Rutgers Cancer Institute of New Jersey, the state's leading cancer center and only National Cancer Institute-Designate

Updated on:February 01,2024 17

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on: May 21,2024 6

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on:May 21,2024 6

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on: June 04,2024 7

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on:June 04,2024 7

Researchers discover possible way to make resistant melanomas susceptible to immunotherapy

by Ludwig Institute for Cancer ResearchMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A Ludwig Cancer Research st

Updated on: June 22,2024 8

Researchers discover possible way to make resistant melanomas susceptible to immunotherapy

by Ludwig Institute for Cancer ResearchMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A Ludwig Cancer Research st

Updated on:June 22,2024 8

Researchers discover new genetic link to premenopausal breast cancer

by University of Alberta Faculty of Medicine & DentistryGraduate student Mahalakshmi Kumaran (left) and professor Sambasivarao Damaraju led a team that discovered a new genetic marker linked

Updated on: June 22,2024 8

Researchers discover new genetic link to premenopausal breast cancer

by University of Alberta Faculty of Medicine & DentistryGraduate student Mahalakshmi Kumaran (left) and professor Sambasivarao Damaraju led a team that discovered a new genetic marker linked

Updated on:June 22,2024 8

Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on: June 08,2024 5

Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on:June 08,2024 5

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on: August 03,2024 0

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on:August 03,2024 0

Patient cost responsibility up for guideline-discordant care

(HealthDay)—For patients with metastatic breast cancer (MBC), receipt of National Comprehensive Cancer Network Guideline-discordant care is associated with higher patient cost responsibility, accordin

Updated on: April 10,2024 11

Patient cost responsibility up for guideline-discordant care

(HealthDay)—For patients with metastatic breast cancer (MBC), receipt of National Comprehensive Cancer Network Guideline-discordant care is associated with higher patient cost responsibility, accordin

Updated on:April 10,2024 11